MIT AI design stabilizes RNA vaccines for up to a year at room temperature
nordicinst · x · 2026-09-28
MIT engineers used small-data machine learning to optimize lipid nanoparticle formulations, making RNA vaccines stable at room temperature for up to a year and removing the ultracold cold-chain bottleneck. The approach could ease distribution in the EU, Nordics, and Brazil, and supports vaccines now being developed for cancer and other diseases.
More from Research
- Inference Engineering Archive launches: end-to-end resource from first principles to production — soham_btw · 2026-09-28
- OpenAI's thousands of agents solved Navier-Stokes; mathematicians worry brute force erases the art — nordicinst · 2026-09-28
- University of Tokyo grows self-healing living human skin on robotic finger — TinfoilTricorn · 2026-09-28
- Thales refines satellite DSMs with diffusion models, cutting urban RMSE from 6.00 to 3.45 m — thalesgroup · 2026-09-28
- Stanford's HomeBody gives frontier VLMs spatial memory and composable humanoid skills — CyberRobooo · 2026-09-28
- MOPD drops OPSD's self-teaching flaw, but naive multi-teacher averaging may distill style over capability — novasarc01 · 2026-09-28